These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29547020)

  • 41. Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study.
    Kroon MW; Wind BS; Beek JF; van der Veen JP; Nieuweboer-Krobotová L; Bos JD; Wolkerstorfer A
    J Am Acad Dermatol; 2011 Mar; 64(3):516-23. PubMed ID: 21255869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ablative erbium:YAG laser treatment of idiopathic chronic inflammatory non-cicatricial balanoposthitis (Zoon's disease)--a series of 20 patients with long-term outcome.
    Wollina U
    J Cosmet Laser Ther; 2010 Jun; 12(3):120-3. PubMed ID: 20429688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison between Er:YAG laser and bipolar radiofrequency combined with infrared diode laser for the treatment of acne scars: Differential expression of fibrogenetic biomolecules may be associated with differences in efficacy between ablative and non-ablative laser treatment.
    Min S; Park SY; Moon J; Kwon HH; Yoon JY; Suh DH
    Lasers Surg Med; 2017 Apr; 49(4):341-347. PubMed ID: 27805273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Idiopathic Guttate Hypomelanosis Treated with 308-nm Excimer Light and Topical Bimatoprost.
    Kreeshan FC; Madan V
    J Cutan Aesthet Surg; 2021; 14(1):115-117. PubMed ID: 34084020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel use of erbium:YAG (2,940-nm) laser for fractional ablative photothermolysis in the treatment of photodamaged facial skin: a pilot study.
    Lapidoth M; Yagima Odo ME; Odo LM
    Dermatol Surg; 2008 Aug; 34(8):1048-53. PubMed ID: 18462427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On the pathogenesis of idiopathic guttate hypomelanosis.
    Falabella R; Escobar C; Giraldo N; Rovetto P; Gil J; Barona MI; Acosta F; Alzate A
    J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):35-44. PubMed ID: 3805391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dermoscopic evaluation of idiopathic guttate hypomelanosis: A preliminary observation.
    Ankad BS; Beergouder SL
    Indian Dermatol Online J; 2015; 6(3):164-7. PubMed ID: 26009709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of a non-ablative, fractional 1565 nm laser for the improvement of striae distensae albae.
    Guertler A; Reinholz M; Steckmeier S; Gauglitz GG
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):220-226. PubMed ID: 30169914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of erbium-doped yttrium aluminium garnet fractional resurfacing laser for treatment of facial acne scars.
    Nirmal B; Pai SB; Sripathi H; Rao R; Prabhu S; Kudur MH; Nayak SU
    Indian J Dermatol Venereol Leprol; 2013; 79(2):193-8. PubMed ID: 23442457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases.
    Cavalié M; Sillard L; Montaudié H; Bahadoran P; Lacour JP; Passeron T
    Dermatol Ther; 2015; 28(2):74-8. PubMed ID: 25471297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes of ablative fractional laser scar treatment.
    Kim DW; Hwang NH; Yoon ES; Dhong ES; Park SH
    J Plast Surg Hand Surg; 2015 Apr; 49(2):88-94. PubMed ID: 24845386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SPF-RR sequential photothermal fractional resurfacing and remodeling with the variable pulse Er:YAG laser and scanner-assisted Nd:YAG laser.
    Marini L
    J Cosmet Laser Ther; 2009 Dec; 11(4):202-11. PubMed ID: 19951189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fractional CO2 laser is an effective therapeutic modality for xanthelasma palpebrarum: a randomized clinical trial.
    Esmat SM; Elramly AZ; Abdel Halim DM; Gawdat HI; Taha HI
    Dermatol Surg; 2014 Dec; 40(12):1349-55. PubMed ID: 25380092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fractional Erbium-Doped Yttrium Aluminum Garnet Laser Versus Microneedling in Treatment of Atrophic Acne Scars: A Randomized Split-Face Clinical Study.
    Osman MA; Shokeir HA; Fawzy MM
    Dermatol Surg; 2017 Jan; 43 Suppl 1():S47-S56. PubMed ID: 28009690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fractional versus ablative erbium:yttrium-aluminum-garnet laser resurfacing for facial rejuvenation: an objective evaluation.
    El-Domyati M; Abd-El-Raheem T; Abdel-Wahab H; Medhat W; Hosam W; El-Fakahany H; Al Anwer M
    J Am Acad Dermatol; 2013 Jan; 68(1):103-12. PubMed ID: 23110966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fractional CO2 laser is as effective as Q-switched ruby laser for the initial treatment of a traumatic tattoo.
    Seitz AT; Grunewald S; Wagner JA; Simon JC; Paasch U
    J Cosmet Laser Ther; 2014 Dec; 16(6):303-5. PubMed ID: 25148407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple fractional erbium: yttrium-aluminum-garnet laser sessions for upper facial rejuvenation: clinical and histological implications and expectations.
    El-Domyati M; Abd-El-Raheem T; Medhat W; Abdel-Wahab H; Al Anwer M
    J Cosmet Dermatol; 2014 Mar; 13(1):30-7. PubMed ID: 24641603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction of post-surgical scarring with the use of ablative fractional CO
    Baca ME; Neaman KC; Rapp DA; Burton ME; Mann RJ; Renucci JD
    Lasers Surg Med; 2017 Jan; 49(1):122-128. PubMed ID: 27060295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined fractional carbon dioxide laser and long-pulsed neodymium : yttrium-aluminium-garnet (1064 nm) laser in treatment of hidradenitis suppurativa; a prospective randomized intra-individual controlled study.
    Abdel Azim AA; Salem RT; Abdelghani R
    Int J Dermatol; 2018 Sep; 57(9):1135-1144. PubMed ID: 29907956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of topical application of B-Resorcinol and Glycyrrhetinic acid monotherapy and in combination with fractional CO
    Grippaudo FR; Di Russo PP
    J Cosmet Dermatol; 2016 Dec; 15(4):413-419. PubMed ID: 27325103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.